Details for 2010825598
Up to date per 01.04.2026
Actions
Details for 2010825598
Granted/Registered
European Patent
29.08.2012 A
08.08.2018 B1
21.10.2009
US
253810 P
C02F 1/28 20060101AFI20131004BHEP
Owner
Revance Therapeutics, Inc.7555 Gateway Boulevard Newark, CA 94560US
Representative
No representatives present
Inventor
RUEGG, Curtis L.826 Shepard Way Redwood City, California 94062US
Information about Fees